浅表性膀胱肿瘤术后联合药物膀胱灌注的治疗进展

The development of intravesical instillation by drug in combined treatment for primary superficial bladder cancer following operation

术后膀胱灌注药物可以提高浅表性膀胱肿瘤(STCC)治疗的效果,联合用药对降低肿瘤的复发率,减少其毒副作用效果明显优于单用药物。本文就浅表性膀胱肿瘤术后联合药物灌注的进展进行综述。

Intravesical chemotherapy after operation may improve the therapeutic effects of primary superficial bladder cancer（ STCC ）, the effects of drug in combined treatment were greater than that alone to reduce primary superficial bladder cancer recurrence and side effect. This development of intravesieal instillation by drug in combined treatment for primary superficial bladder cancer following operation will be summed Up as follows.